A significant discovery in cancer investigation is occurring with the use of VHH fragments to reactivate damaged p53. This essential malignant protector protein is frequently inactivated in several types of tumors, https://socialnetworkadsinfo.com/story23690433/mini-antibodies-reactivate-the-p53-protein-a-promising-pathway-for-cancer-therapy